Rural Georgians may find it difficult to access medication that could slow the progression of Alzheimer's disease, according ...

A new study, published today in Nature Communications, offers clues into how APOE isoforms differentially affect human ...

Some 24 per cent of trial participants receiving the drug experienced brain swelling. Although 75% of people who developed ...

Researchers in a new study found that the drug showed an ability to protect the brain in a certain way, which is a critical ...

Scientists have been working hard for many years to understand what causes Alzheimer’s and how to stop it. One of the key ...

A new study highlights how Alzheimer’s disease-associated proteins differentially affect tissues in a whole organism.

Scientists have discovered a new drug that protects the brain’s blood-brain barrier (BBB), a key defense against Alzheimer’s ...

Alzheimer's disease is the most common form of dementia in the UK, and the risk of developing it increases with age - but a ...

Alzheimer’s disease is the most common type of dementia. It involves cognitive decline caused by a build-up of abnormal ...

Heat can be dangerous for anyone but warmer temperatures can pose additional challenges for people living with Alzheimer’s ...

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto ...